BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4084224)

  • 1. 3-Phosphonopropionic acids inhibit carboxypeptidase A as multisubstrate analogues or transition-state analogues.
    Grobelny D; Goli UB; Galardy RE
    Biochem J; 1985 Nov; 232(1):15-9. PubMed ID: 4084224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ionization states of the complex formed between 2-benzyl-3-phosphonopropionic acid and carboxypeptidase A.
    Goli UB; Grobelny D; Galardy RE
    Biochem J; 1988 Sep; 254(3):847-53. PubMed ID: 3196297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of carboxypeptidase A by ketones and alcohols that are isosteric with peptide substrates.
    Grobelny D; Goli UB; Galardy RE
    Biochemistry; 1985 Dec; 24(26):7612-7. PubMed ID: 4092029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of carboxypeptidase A by aldehyde and ketone substrate analogues.
    Galardy RE; Kortylewicz ZP
    Biochemistry; 1984 Apr; 23(9):2083-7. PubMed ID: 6547054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha-Bromo ketone substrate analogues are powerful reversible inhibitors of carboxypeptidase A.
    Galardy RE; Kortylewicz ZP
    Biochemistry; 1985 Dec; 24(26):7607-12. PubMed ID: 4092028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphonate analogues of carboxypeptidase A substrates are potent transition-state analogue inhibitors.
    Hanson JE; Kaplan AP; Bartlett PA
    Biochemistry; 1989 Jul; 28(15):6294-305. PubMed ID: 2790000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of the complex of carboxypeptidase A with a strongly bound phosphonate in a new crystalline form: comparison with structures of other complexes.
    Kim H; Lipscomb WN
    Biochemistry; 1990 Jun; 29(23):5546-55. PubMed ID: 2386784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of potent and specific inhibitors of carboxypeptidases A and B.
    Ondetti MA; Condon ME; Reid J; Sabo EF; Cheung HS; Cushman DW
    Biochemistry; 1979 Apr; 18(8):1427-30. PubMed ID: 427123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoro ketone inhibitors of hydrolytic enzymes.
    Gelb MH; Svaren JP; Abeles RH
    Biochemistry; 1985 Apr; 24(8):1813-7. PubMed ID: 2990541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The unusual behavior of the inhibitor S(+)(1-amino-2-phenylethyl)phosphonic acid towards carboxypeptidase A.
    Bal W; Bertini I; Kozlowski H; Monnanni R; Scozzafava A; Siatecki GZ
    J Inorg Biochem; 1990 Nov; 40(3):227-35. PubMed ID: 2292683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of the by-product analog benzylsuccinic acid by carboxypeptidase A.
    Byers LD; Wolfenden R
    Biochemistry; 1973 May; 12(11):2070-8. PubMed ID: 4735879
    [No Abstract]   [Full Text] [Related]  

  • 12. Stereoselective inhibition of glutamate carboxypeptidase by chiral phosphonothioic acids.
    Lu H; Berkman CE
    Bioorg Med Chem; 2001 Feb; 9(2):395-402. PubMed ID: 11249132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potent reversible inhibitor of carboxypeptidase A.
    Byers LD; Wolfenden R
    J Biol Chem; 1972 Jan; 247(2):606-8. PubMed ID: 5061899
    [No Abstract]   [Full Text] [Related]  

  • 14. 9-[(Phosphonoalkyl)benzyl]guanines. Multisubstrate analogue inhibitors of human erythrocyte purine nucleoside phosphorylase.
    Kelley JL; Linn JA; McLean EW; Tuttle JV
    J Med Chem; 1993 Oct; 36(22):3455-63. PubMed ID: 8230137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of the complex of L-benzylsuccinate with wheat serine carboxypeptidase II at 2.0-A resolution.
    Bullock TL; Branchaud B; Remington SJ
    Biochemistry; 1994 Sep; 33(37):11127-34. PubMed ID: 7727364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affinity labelling of carboxypeptidase B: modification of a methionyl residue.
    Zisapel N; Sokolovsky M
    Biochem Biophys Res Commun; 1974 Jun; 58(4):951-9. PubMed ID: 4857892
    [No Abstract]   [Full Text] [Related]  

  • 17. Sulfamide derivatives as transition state analogue inhibitors for carboxypeptidase A.
    Park JD; Kim DH
    Bioorg Med Chem; 2004 May; 12(9):2349-56. PubMed ID: 15080932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-(Hydroxyaminocarbonyl)phenylalanine: a novel class of inhibitor for carboxypeptidase A.
    Chung SJ; Kim DH
    Bioorg Med Chem; 2001 Jan; 9(1):185-9. PubMed ID: 11197339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic insight into the inactivation of carboxypeptidase A by alpha-benzyl-2-oxo-1,3-oxazolidine-4-acetic acid, a novel type of irreversible inhibitor for carboxypeptidase A with no stereospecificity.
    Chung SJ; Chung S; Lee HS; Kim EJ; Oh KS; Choi HS; Kim KS; Kim YJ; Hahn JH; Kim DH
    J Org Chem; 2001 Sep; 66(19):6462-71. PubMed ID: 11559199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphonamidate analogues of dipeptides with carboxypeptidase A and beta-lactamase-inhibitory activity: elucidation of the mechanism of beta-lactamase inhibition by electrospray mass spectrometry.
    Payne DJ; Bateson JH; Tolson D; Gasson B; Khushi T; Ledent P; Frère JM
    Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):457-61. PubMed ID: 8670057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.